Stomach cancer is challenging to detect early due to vague symptoms, often diagnosed at advanced stages. Diagnosis involves ...

The Las Vegas Medical District is set to expand with a new testing facility that officials say will strengthen the region’s ...

Bent bone dysplasia (BBD) is a perinatal-lethal skeletal disorder caused by pathogenic FGFR2 mutations that disrupt bone ...

Multigene next-generation sequencing (NGS) performed directly on tumor tissue can accurately identify pathogenic variants in epithelial ovarian cancer (EOC), detecting both somatic and germline ...

Circulating tumor DNA (ctDNA) is a promising biomarker for monitoring treatment response and progression-free survival in ...

Although COVID-19 testing decreased during the study period, influenza and respiratory syncytial virus testing increased among hospitalized youth.

Triple-negative breast cancer is one of the most aggressive cancers. The name tells the story: It lacks the three main ...

Benchmark anticipates that Abbott’s Diagnostics business will pick up speed again in 2026 with the introduction of a new ...

From intensifying therapy in ctDNA-positive bladder cancer to scaling it back in ctDNA-negative colon cancer, new data from ...

Procyon is a new cancer diagnostics spinout from Queen Mary University of London which has just completed an oversubscribed ...